Security key
00287Y109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 1,020,107,599
- Total 13F value
- $74,140,080,434
- Share change
- +2,083,958
- Put/Call ratio
- 100%
- SEC-reported price per share
- $72.72
- Number of holders
- 2,013
- Value change
- +$134,418,416
- Number of buys
- 1,006
- Number of sells
- 868
- Shares outstanding
- 1,769,960,826
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2019
Institutions
2,013
Top holders
10
ABBV full security history
Ownership snapshot
Full 13F holder table
AbbVie Inc. SEC filings
AbbVie Inc. company facts
AbbVie Inc. 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of ABBV - AbbVie Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
0/15
Latest evidence
31 Mar 2019
13F
Highest disclosed value: $11,807,108,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors has the largest disclosed position value at $11.81B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital Research Global Investors's linked filing trail.
Disclosed position value
Top 5
Capital Research Global Investors
$11.81B
VANGUARD GROUP INC
$9.74B
BlackRock Finance, Inc.
$7.67B
STATE STREET CORP
$5.33B
Capital International Investors
$1.99B
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
Company
|
—
denominator unverified
|
$11,807,108,000
146,508,345 shares
|
— | 31 Mar 2019 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$9,738,830,000
120,844,140 shares
|
— | 31 Mar 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$7,671,760,000
95,194,963 shares
|
— | 31 Mar 2019 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$5,334,939,000
66,198,521 shares
|
— | 31 Mar 2019 |
| Capital International Investors |
13F
Company
|
—
denominator unverified
|
$1,987,258,000
24,658,867 shares
|
— | 31 Mar 2019 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$1,722,483,000
21,404,788 shares
|
— | 31 Mar 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2,013
Shares
1,020,107,599
Rows available
2,013
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
2,023
Q2 2019 holders
2,013
Holder diff
-10
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q2 2019 value | Value change | Value Chg % |
|---|